Effects of Y-39983, a Selective Rho-Associated Protein Kinase Inhibitor, on Blood Flow in Optic Nerve Head in Rabbits and Axonal Regeneration of Retinal Ganglion Cells in Rats

REFERENCES

• Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004;363:1711–1720.
   PubMed Web of Science ®Google Scholar
• Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol 1994;39:23–42.
   PubMed Web of Science ®Google Scholar
• Flammer J. The vascular concept of glaucoma. Surv Ophthalmol 1994;38 Suppl:S3–S6.
   Google Scholar
• Geijssen HC. Studies on Normal Pressure Glaucoma. New York: Kugler;1991:195–213.
   Google Scholar
• Araie M, Sekine M, Suzuki Y, Koseki N. Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma. Ophthalmology 1994;101:1440–1444.
   PubMed Web of Science ®Google Scholar
• Narumiya S. The small GTPase Rho: cellular functions and signal transduction. J Biochem 1996;120:215–228.
   PubMed Web of Science ®Google Scholar
• Narumiya S, Ishizaki T, Watanabe N. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett 1997;410:68–72.
   PubMed Web of Science ®Google Scholar
• Paterson HF, Self AJ, Garrett MD, Just I, Aktories K, Hall A. Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol 1990;111:1001–1007.
   PubMed Web of Science ®Google Scholar
• Takaishi K, Sasaki T, Kato M et al. Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene 1994;9:273–279.
   PubMed Web of Science ®Google Scholar
• Kishi K, Sasaki T, Kuroda S, Itoh T, Takai Y. Regulation of cytoplasmic division of Xenopus embryo by Rho p21 and its inhibitory GDP/GTP exchange protein (Rho GDI). J Cell Biol 1993;120:1187–1195.
   PubMed Web of Science ®Google Scholar
• Hirata K, Kikuchi A, Sasaki T et al. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 1992;267:8719–8722.
   PubMed Web of Science ®Google Scholar
• Gong MC, Iizuka K, Nixon G et al. Role of guanine nucleotide-binding proteins–ras-family or trimeric proteins or both–in Ca2+ sensitization of smooth muscle. Proc Natl Acad Sci USA 1996;93:1340–1345.
   PubMedGoogle Scholar
• Ishizaki T, Maekawa M, Fujisawa K et al. The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J 1996;15:1885–1893.
   PubMed Web of Science ®Google Scholar
• Kaufman PL. Pressure-dependent outflow. In: Hart WM, eds. Alder’s Physiology of the Eye: Clinical Application, 9th ed. St. Louis: Mosby;1992:307–335.
   Google Scholar
• Epstein DL, Rohen JW. Morphology of the trabecular meshwork and inner-wall endothelium after cationized ferritin perfusion in the monkey eye. Invest Ophthalmol Vis Sci 1991;32:160–171.
   PubMed Web of Science ®Google Scholar
• Tian B, Geiger B, Epstein DL, Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci 2000;41:619–623.
   PubMed Web of Science ®Google Scholar
• Uehata M, Ishizaki T, Satoh H et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389:990–994.
   PubMed Web of Science ®Google Scholar
• Honjo M, Tanihara H, Inatani M et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 2001;42:137–144.
   PubMed Web of Science ®Google Scholar
• Waki M, Yoshida Y, Oka T, Azuma M. Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Curr Eye Res 2001;22:470–474.
   PubMed Web of Science ®Google Scholar
• Rao PV, Deng PF, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci 2001;42:1029–1037.
   PubMed Web of Science ®Google Scholar
• Tokushige H, Inatani M, Nemoto S et al. Effects of topical administration of Y-39983, a selective Rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest Ophthalmol Vis Sci 2007;48:3216–3222.
   PubMed Web of Science ®Google Scholar
• Tanihara H, Inatani M, Honjo M, Tokushige H, Azuma J, Araie M. Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch Ophthalmol 2008;126:309–315.
   PubMed Web of Science ®Google Scholar
• Hirose M, Ishizaki T, Watanabe N et al. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J Cell Biol 1998;141:1625–1636.
   PubMed Web of Science ®Google Scholar
• Tamaki Y, Kawamoto E, Araie M, Eguchi S, Fujii H. An application of laser speckle phenomenon for noninvasive two-dimensional evaluation of microcirculation in ocular fundus–a preliminary report. Jpn J Ophthalmol 1993;37:178–186.
   Google Scholar
• Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res 1995;60:373–383.
   PubMed Web of Science ®Google Scholar
• Barres BA, Silverstein BE, Corey DP, Chun LL. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron 1988;1:791–803.
   PubMed Web of Science ®Google Scholar
• Otori Y, Wei JY, Barnstable CJ. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci 1998;39:972–981.
   PubMed Web of Science ®Google Scholar
• Nakajima E, Nakajima T, Minagawa Y, Shearer TR, Azuma M. Contribution of ROCK in contraction of trabecular meshwork: proposed mechanism for regulating aqueous outflow in monkey and human eyes. J Pharm Sci 2005;94:701–708.
   PubMed Web of Science ®Google Scholar
• Quan MZ, Kosaka J, Watanabe M, Wakabayashi T, Fukuda Y. Survival of axotomized retinal ganglion cells in peripheral nerve-grafted ferrets. Invest Ophthalmol Vis Sci 1999;40:2360–2366.
   Google Scholar
• Mizuno K, Koide T, Saito N et al. Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys. Invest Ophthalmol Vis Sci 2002;43:3243–3250.
   PubMed Web of Science ®Google Scholar
• Mizuno K, Koide T, Shimada S, Mori J, Sawanobori K, Araie M. Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina. Invest Ophthalmol Vis Sci 2009;50:2839–2847.
   PubMed Web of Science ®Google Scholar
• Takayama J, Tomidokoro A, Tamaki Y, Araie M. Time course of changes in optic nerve head circulation after acute reduction in intraocular pressure. Invest Ophthalmol Vis Sci 2005;46:1409–1419.
   PubMedGoogle Scholar
• Osborne NN, Melena J, Chidlow G, Wood JP. A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br J Ophthalmol 2001;85:1252–1259.
   PubMed Web of Science ®Google Scholar
• Osborne NN, Ugarte M, Chao M et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 1999;43 Suppl 1:S102–S128.
   Google Scholar
• Sugiyama T, Shibata M, Kajiura S et al. Effects of fasudil, a Rho-associated protein kinase inhibitor, on optic nerve head blood flow in rabbits. Invest Ophthalmol Vis Sci 2011;52:64–69.
   PubMed Web of Science ®Google Scholar
• Rao VP, Epstein DL. Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma. BioDrugs 2007;21:167–177.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003;6:461–467.
   PubMed Web of Science ®Google Scholar
• Sandvig A, Berry M, Barrett LB, Butt A, Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004;46:225–251.
   PubMed Web of Science ®Google Scholar
• Mueller BK, Mack H, Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 2005;4:387–398.
   PubMed Web of Science ®Google Scholar
• Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU, Henke-Fahle S. Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Invest Ophthalmol Vis Sci 2009;50:452–461.
   PubMed Web of Science ®Google Scholar
• Sagawa H, Terasaki H, Nakamura M et al. A novel ROCK inhibitor, Y-39983, promotes regeneration of crushed axons of retinal ganglion cells into the optic nerve of adult cats. Exp Neurol 2007;205:230–240.
   PubMed Web of Science ®Google Scholar